This topic contains a solution. Click here to go to the answer

Author Question: An Olympic skier moving at 22.0 m/s down a 30.0 slope encounters a region of wet snow, of ... (Read 88 times)

kfurse

  • Hero Member
  • *****
  • Posts: 590
An Olympic skier moving at 22.0 m/s down a 30.0 slope encounters a region of wet snow, of coefficient of friction k = 0.740 . How far down the slope does she go before stopping?
 a. 119 m
  c. 175 m
  b. 145 m
  d. 199 m

Question 2

Dana uses a rope to pull a box that weighs 300 N across a level surface with constant velocity. The rope makes an angle of 30 above the horizontal and the tension in the rope is 50 N. What is the coefficient of friction?
 a. 0.35
  c. 0.16
  b. 0.29
  d. 0.20



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Sarahjh

  • Sr. Member
  • ****
  • Posts: 370
Answer to Question 1

C

Answer to Question 2

C




kfurse

  • Member
  • Posts: 590
Reply 2 on: Jul 28, 2018
Wow, this really help


upturnedfurball

  • Member
  • Posts: 334
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

Illness; diuretics; laxative abuse; hot weather; exercise; sweating; caffeine; alcoholic beverages; starvation diets; inadequate carbohydrate consumption; and diets high in protein, salt, or fiber can cause people to become dehydrated.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library